rs1555891562
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PP2PP3_ModeratePP5_Moderate
The NM_000516.7(GNAS):c.742G>A(p.Val248Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Consequence
GNAS
NM_000516.7 missense
NM_000516.7 missense
Scores
16
1
2
Clinical Significance
Conservation
PhyloP100: 9.47
Genes affected
GNAS (HGNC:4392): (GNAS complex locus) This locus has a highly complex imprinted expression pattern. It gives rise to maternally, paternally, and biallelically expressed transcripts that are derived from four alternative promoters and 5' exons. Some transcripts contain a differentially methylated region (DMR) at their 5' exons, and this DMR is commonly found in imprinted genes and correlates with transcript expression. An antisense transcript is produced from an overlapping locus on the opposite strand. One of the transcripts produced from this locus, and the antisense transcript, are paternally expressed noncoding RNAs, and may regulate imprinting in this region. In addition, one of the transcripts contains a second overlapping ORF, which encodes a structurally unrelated protein - Alex. Alternative splicing of downstream exons is also observed, which results in different forms of the stimulatory G-protein alpha subunit, a key element of the classical signal transduction pathway linking receptor-ligand interactions with the activation of adenylyl cyclase and a variety of cellular reponses. Multiple transcript variants encoding different isoforms have been found for this gene. Mutations in this gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progressive osseus heteroplasia, polyostotic fibrous dysplasia of bone, and some pituitary tumors. [provided by RefSeq, Aug 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
PM1
In a strand (size 7) in uniprot entity GNAS2_HUMAN there are 10 pathogenic changes around while only 0 benign (100%) in NM_000516.7
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), GNAS. . Gene score misZ 2.6546 (greater than the threshold 3.09). Trascript score misZ 4.8361 (greater than threshold 3.09). GenCC has associacion of gene with ACTH-independent macronodular adrenal hyperplasia 1, pseudohypoparathyroidism type 1B, pseudohypoparathyroidism type 1C, pseudohypoparathyroidism type 1A, progressive osseous heteroplasia, pseudopseudohypoparathyroidism, McCune-Albright syndrome.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.906
PP5
Variant 20-58909707-G-A is Pathogenic according to our data. Variant chr20-58909707-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 521825.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNAS | NM_000516.7 | c.742G>A | p.Val248Met | missense_variant | 10/13 | ENST00000371085.8 | NP_000507.1 | |
GNAS | NM_016592.5 | c.*648G>A | 3_prime_UTR_variant | 10/13 | ENST00000371075.7 | NP_057676.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNAS | ENST00000371085.8 | c.742G>A | p.Val248Met | missense_variant | 10/13 | 1 | NM_000516.7 | ENSP00000360126.3 | ||
GNAS | ENST00000676826.2 | c.2674G>A | p.Val892Met | missense_variant | 10/13 | ENSP00000504675.2 | ||||
GNAS | ENST00000371102.8 | c.2629G>A | p.Val877Met | missense_variant | 9/12 | 5 | ENSP00000360143.4 | |||
GNAS | ENST00000354359.12 | c.745G>A | p.Val249Met | missense_variant | 10/13 | 1 | ENSP00000346328.7 | |||
GNAS | ENST00000371095.7 | c.700G>A | p.Val234Met | missense_variant | 9/12 | 1 | ENSP00000360136.3 | |||
GNAS | ENST00000470512.6 | c.568G>A | p.Val190Met | missense_variant | 10/13 | 5 | ENSP00000499552.2 | |||
GNAS | ENST00000480232.6 | c.568G>A | p.Val190Met | missense_variant | 11/14 | 5 | ENSP00000499545.2 | |||
GNAS | ENST00000663479.2 | c.568G>A | p.Val190Met | missense_variant | 10/13 | ENSP00000499353.2 | ||||
GNAS | ENST00000462499.6 | c.523G>A | p.Val175Met | missense_variant | 9/12 | 2 | ENSP00000499758.2 | |||
GNAS | ENST00000467227.6 | c.523G>A | p.Val175Met | missense_variant | 10/13 | 3 | ENSP00000499681.2 | |||
GNAS | ENST00000478585.6 | c.523G>A | p.Val175Met | missense_variant | 9/12 | 2 | ENSP00000499762.2 | |||
GNAS | ENST00000481039.6 | c.523G>A | p.Val175Met | missense_variant | 9/12 | 5 | ENSP00000499767.2 | |||
GNAS | ENST00000485673.6 | c.523G>A | p.Val175Met | missense_variant | 9/12 | 5 | ENSP00000499334.2 | |||
GNAS | ENST00000488546.6 | c.523G>A | p.Val175Met | missense_variant | 9/12 | 5 | ENSP00000499332.2 | |||
GNAS | ENST00000492907.6 | c.523G>A | p.Val175Met | missense_variant | 9/12 | 3 | ENSP00000499443.2 | |||
GNAS | ENST00000371075.7 | c.*648G>A | 3_prime_UTR_variant | 10/13 | 1 | NM_016592.5 | ENSP00000360115.3 | |||
GNAS | ENST00000453292.7 | c.*603G>A | 3_prime_UTR_variant | 9/12 | 5 | ENSP00000392000.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 33
GnomAD4 exome
Cov.:
33
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | May 24, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Pathogenic
D;.;.;D;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
.;.;.;H;.;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N;N;N;N
REVEL
Pathogenic
Sift
Pathogenic
D;D;D;D;D;D
Sift4G
Pathogenic
D;D;D;D;D;D
Polyphen
D;.;.;D;.;D
Vest4
MutPred
Loss of catalytic residue at V891 (P = 0.0116);.;.;.;.;.;
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at